GA-AGCO
16.10.2018 14:02:06 CEST | Business Wire | Press release
AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and solutions, today announces that Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO Corporation, has been named a Chevalier (Knight) of the Légion d'Honneur (Legion of Honor) by the government of France. This high-ranking honorary decoration was bestowed during a recent ceremony held at AGCO’s global headquarters in Duluth, in the presence of the French Consul General in Atlanta, Louis de Corail.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005270/en/
The Legion of Honor, established by Napoléon Bonaparte in 1802, is the highest distinction conferred by the government of France. It is awarded to recognize those people and organizations that have made outstanding contributions to France in a variety of fields.
AGCO began operations in France, when the group became the parent company of the Massey Ferguson brand in 1994, taking ownership of the Beauvais Massey Ferguson plant. Opened in 1960, the Beauvais AGCO site remains today the Global Centre of Excellence for Massey Ferguson engineering and manufacturing, as well as the first private employer of the whole Picardie region. Summing up its operations from Beauvais, Ennery and Courcouronnes, as well as its joint ventures GIMA and AGCO Finance, AGCO has approximately 2,500 employees in the country. As continental Europe's second largest economy, and one of the largest markets for farm machinery, France represents a strategically important market for AGCO. In France, AGCO actively drives business activities centered on the design, manufacture and distribution of farm machinery, strongly contributing to the French economy.
This decoration is in recognition, under Martin Richenhagen’s leadership, of AGCO’s contributions to the development of France and France-USA relations.
Conferring the Legion of Honor on behalf of French President Emmanuel Macron, Dr. Monique Seefried, Chevalier in the Order of the Legion of Honor said: "I would like to thank Martin Richenhagen for his personal commitment and trust in our country's economy. I pay tribute, through him, to the strength of AGCO Corporation, a global leader in the design, manufacture and distribution of agricultural machinery and solutions, and to its willingness to expand and develop in Europe, and especially in France where AGCO’s French-made tractors are admired and respected. Tractors embody our past and our future, linking our ancient human roots in agriculture to the technological progress of the 20th century. Tractors bring us back to the land, to the oldest profession of farming while heralding the power of machinery and industry.”
Martin Richenhagen commented: “It is indeed an honor and privilege to receive this prestigious decoration from the French Government. I am delighted and proud to have our French operations receive such high recognition. In developing our business in Europe, a region which for AGCO is first in revenue contribution, France is a strategic market of great importance. During the past six years, we have invested more than 300 million euros in our Beauvais and Ennery operations, creating close to 300 new jobs to support our ambition for growth. This would not have been possible without the outstanding commitment of our 2,500 employees and this recognition is also theirs. We truly consider France as a business friendly environment supported by an entrepreneurial policy led by President Emmanuel Macron. We hope to make ever-more progress in our development, to contribute to further growing the relationship between France and the USA.”
Martin Richenhagen was selected by the Board of Directors in March 2004 as President and Chief Executive Officer of AGCO Corporation. He was appointed to Chairman of the Board on August 15, 2006.
Under his leadership, AGCO’s operations in France has been through outstanding transformation and success including the following key milestones:
- 2013 – The Beauvais 2 Cab facility and International Sales Training Centre for the Massey Ferguson brand opens. This 15.5 million euros investment created 100 new jobs.
- 2016 – The Beauvais site receives two coveted awards: Best Foreign Exporter 2016 as the first producer and exporter of farm machinery in France; and Factory of Year 2016 for its lean manufacturing implementation and number one in quality approach.
- 2017 – At Ennery, AGCO’s European Parts Warehouse and Distribution Centre moves from 30,000 m² to 100,000 m² and will create 62 jobs by the end of 2018 after a 2.1 million euros investment.
- 2018 – Only five years after the opening of its new cab facility, on August 28th , AGCO launches the operations of its new Logistic Centre in Beauvais after investing another 11 million euros and creating 103 new jobs.
About AGCO
AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural solutions and supports more productive farming through its full line of equipment and related services. AGCO products are sold through five core brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by Fuse® precision technologies and farm optimization services. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2017, AGCO had net sales of approximately $8.3 billion. For more information, visit http://www.AGCOcorp.com . For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181016005270/en/
Contact:
AGCO Ulrich Stockheim, +1 770-813-6002 Chief Communications Officer Ulrich.Stockheim@AGCOcorp.com Cell: +49 1732993545 or Xavier Arruego, +33 3 44 11 29 40 Manager, Public Relations AGCO EME Xavier.Arruego@AGCOcorp.com Cell: +33 6 70 65 77 00
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
